Inovio Pharmaceuticals (INO) Prices Offering of Common Stock and Warrants

March 7, 2013 6:34 AM EST Send to a Friend
Inovio Pharmaceuticals, Inc. (NYSE: INO) priced an underwritten offering of 27,377,266 shares of its common stock and warrants to purchase up to 13,688,633 shares of common stock at a combined price to the public of $0.55 per share and related warrant for gross proceeds of $15.1 million. The warrants are exercisable at an exercise price of $.7936 per share and will expire, unless exercised, on the date that is 180 days after the fifth anniversary of the date of issuance.

Inovio intends to use the net proceeds received from the sale of the securities (including any resulting from the exercise of the warrants) for general corporate purposes, including clinical trial expenses, research and development expenses, general and administrative expenses, manufacturing expenses and potential acquisitions of companies and technologies that complement our business.

Cowen and Company, LLC is acting as sole book-running manager for the offering. Brean Capital, LLC is acting as co-lead manager for the offering. Maxim Group LLC is acting as co-manager.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Equity Offerings

Related Entities

Maxim Group, Cowen & Co

Add Your Comment